Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

Author： Cheng Yee Chung   Ueno Naoto T  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.6, Iss.4, 2010-07, pp. : 481-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 131-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation for Patients with Advanced Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 272-274

Karger

Access to resources Recommend Favorite

Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

High-Dose Idarubicin, Busulphan and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma Responsive to DAV Chemotherapy: Comparison with a Historical Control

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 9-14

Karger

Access to resources Recommend Favorite